pirenzepine

  1. V

    Winsantor Phase 2 small fiber neuropathy drug (WST-057) trial news.

    I recieved this newsletter and could not find it posted on the Internet, so I thought I’d post the text. This is a newsletter from a small company, Winsantor, who is testing a topical drug (WST-057) to see if it increases small fiber nerve density (and improve symptoms?) in diabetic patients...
Back
Top Bottom